Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer.
Charlotte S Voskuilen
,
Michiel S van der Heijden
,
Bas W G van Rhijn
More about this publication
European urology
Volume
76
Issue nr.
6
Pages
870-871
Publication date
01-12-2019
Full text links
Publisher website (DOI)
10.1016/j.eururo.2019.07.019
Europe PubMed Central
31351667
Pubmed
31351667